Table 1.
Patient characteristics
| Total n = 211 | Mild/moderate AD n = 141 | Severe AD n = 70 | P-value † | |
|---|---|---|---|---|
|
Female, n (%)
†
|
138 (65.4) |
102 (72.3) |
36 (51.4) |
0.003* |
|
Age, year
1,2
|
28.0 (22.0-44.0) |
26.0 (21.0-42.0) |
39.0 (26.0-49.0) |
< 0.001* |
|
Total IgE, kU/L
1,2,3
|
1455.0 (372.5-5000) |
694 (171-2099) |
5000 (1884.5-5000) |
< 0.001* |
|
TARC, pg/mL
1,2,4
|
1328.0 (470.0-3908.0) |
743 (336.3-1683.3) |
2826 (1682-7819) |
< 0.001* |
|
SASSAD
1,2,4
|
21.0 (10.0-31.0) |
17.0 (8.0-27.8) |
24.0 (18.0-38.0) |
< 0.001* |
|
Other atopic diseases: |
|
|
|
|
|
Asthma,
5
†
n (%) |
102 (49.8) |
68 (49.3) |
34 (50.7) |
0.843 |
|
AR, seasonal, tree/grass,
6
†
n (%) |
131 (64.9) |
88 (64.2) |
43 (66.2) |
0.789 |
| AR, cat/dog, 7 † n (%) | 100 (55.2) | 67 (53.6) | 33 (58.9) | 0.505 |
1Median (IQR); 2p < 0.001; Mann–Whitney U-test; 3In subgroups mild/moderate (n = 65) versus severe AD (n = 36); 4In subgroups mild/moderate (n = 92) versus severe AD (n = 51); 5Unknown in n = 6; 6Unknown in n = 9; 7Unknown in n = 30; *p < 0.01.
†Chi-square; mild/moderate versus severe AD.